---
created: 2025-04-13
updated: 2025-04-13T10:52
id: kp#b/w>+jB
specialty: pharmaco
specialty_id: 296
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::01-basic-pharm::01-general::04-drug-elimination
  - "source/ak-step1-v11:": 
  - theme/firstaid::05-pharmacology::01-pharmacokinetics-pharmacodynamics::04-drug-metabolism
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::15-pharm-fundamentals::03-drug-metabolism,-elimination,-and-urine-ph
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::!general-pharmacology
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::1000-1999::1253
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::1000-1999::1712
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield"
type: flashcard
---

# Question
Patients who are slow **acetylators / metabolizers** have increased side effects from certain drugs (eg, isoniazid, dapsone, hydralazine, and procainamide) due to decreased rate of metabolism

---

# Answer
